The National Institute of Neurological Disorders and Stroke indicated in 2010 that tension type headaches (TTH) which are the most common and persistent affect two thirds of adult males and 80% of females. The International Headache Society argues that over 3,000 migraine attacks occur daily in every 1 million of the general population but still the problem is underestimated. If you suffer from persistent headaches, the world renowned pharmaceutical companies have just what you need to get on with your day. Saridon an analgesic combining caffeine (50mg), propyphenazone (150mg) and paracetamol (250mg) is creating a buzz due to its effectiveness but its magic lies in the ingredients used.
How Saridon Works
The nagging problem with most analgesics is the slow onset of actions and duration of effectiveness. Paracetamol has a slow onset of action but its effects last longer. On the other hand, propyphenazone a non-steroidal anti-inflammatory drug (NSAID) has a faster onset but lower duration of effectiveness. By mixing the two, the drug’s onset time increased faster as did the duration of action by about 77 minutes. Caffeine is a stimulant that creates alertness and increased mental focus. The patient is thus able to clear the haze created by the pain and within 15 minutes, the headache is totally gone.
Effectiveness of Saridon
To appreciate why the product has peaked in popularity, one needs to check statistics from various studies. A Boitel study in 1996 for example indicated that 89.5% of patients surveyed judged the drug as very good and pain reduction was noted within 15 minutes which continued over 45 subsequent minutes. In further studies in 2002 and 2009, the efficacy of the drug was rated at 98% and when compared to other analgesics then, the pain reduction time was better. Surprisingly, the drug needs just a dosage of 1-2 tablets and the side effects are medically negligible. The drug is a non-prescription medication but if you are hypersensitive to phenazone, caffeine and paracetamol containing products there will be counter-indication. With WHO indicating work efficiency and social activity are reduced in 60% of migraine and TTH sufferers, getting a quick solution through Saridon is the only solution. This mediation is available in Europe, Latin America, Asia and Africa and hence availability cannot be an excuse.
